US76200L3096 - Common Stock
REZOLUTE INC
NASDAQ:RZLT (4/30/2024, 7:22:46 PM)
2.68
+0.07 (+2.68%)
Rezolute, Inc. operates as a biopharmaceutical company, which engages in the development of drug therapies for patients with metabolic and orphan diseases. The company is headquartered in Redwood City, California and currently employs 51 full-time employees. The company went IPO on 2011-12-23. The Company’s lead clinical asset, RZ358, is in late-stage development for the treatment of congenital hyperinsulinism (HI), an ultra-rare pediatric genetic disorder characterized by excessive production of insulin by the pancreas in Phase III. RZ358 is an intravenously administered human monoclonal antibody that binds to a unique site (allosteric) on the insulin receptor in insulin target tissues, such as in the liver, fat and muscle. Its second clinical asset, RZ402, is an oral plasma kallikrein inhibitor (PKI) being developed as a therapy for the chronic treatment of diabetic macular edema (DME) in Phase II. RZ402 is designed to be a once daily oral therapy for the treatment of DME and unlike the anti-VEGF therapies, RZ402 targets the Kallikrein-Kinin System to address inflammation and vascular leakage.
REZOLUTE INC
275 Shoreline Drive, Suite 500
Redwood City CALIFORNIA 94065
P: 16502064507
CEO: Nevan Elam
Employees: 51
Website: https://www.rezolutebio.com/
Discover three biotech stocks with explosive growth potential. Don't miss out on these great picks this year.
Potential to more than double the addressable patient population living with hypoglycemia resulting from insulin receptor over-activation (tumor hyperinsulinism)
Potential to more than double the addressable patient population living with hypoglycemia resulting from insulin receptor over-activation (tumor...
Phase 3 clinical study of RZ358 underway in patients with congenital hyperinsulinism (cHI); topline results expected in mid-2025 Benefit shown in...
Here you can normally see the latest stock twits on RZLT, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: